Case Study
First Gene Therapy Approved in EuropeVeristat was brought in to create and manage a full development program for a gene therapy for a very rare inherited disorder. The work involved charting the course in unexplored waters ...
Case Study
Writing Multiple Marketing Applications At The Same TimeA mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s Marketing Authorization ...
Case Study
Stem Cell Therapy for Stroke PatientsA client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in patients following an ischemic stroke. The goal was to look at limb recovery time and level ...
Case Study
Complex Trial for a Rare Pediatric Gene TherapyA clinical-stage biotechnology start-up asked Veristat to run a new European trial of their complex gene therapy. Veristat experts complimented the client’s team taking on their first ...
Case Study
Full Service Support for A Gene Therapy TrialA clinical-stage biotechnology start-up asked Veristat to run complex US and EU trials of their unique gene therapy.
Case Study
Site Monitoring Success With TeamworkImagine you are getting ready to launch the third drug cohort of your early phase clinical trial for a pancreatic cancer vaccine study and your in-house lead CRA overseeing your sites in ...
Case Study
Preparing a New Drug Application (IND)Veristat has collaborated with biopharmaceutical firms on the preparation of over 50 INDs. Learn how we successfully helped a sponsor finalize their IND in under 6 weeks.
Case Study
Medical Writing Partnership - IND to NDALearn how the Veristat medical writing team partnered with a sponsor and supported their entire rare oncology program from IND to NDA.
Case Study
Rapid Response to Ebola OutbreakWhen the WHO declared the Ebola Outbreak of 2014 in Africa a Global Health Emergency, Veristat was contacted to quickly set up clinical trial sites. Learn how we overcame the urgency ...
